We describe the latest criteria for the diagnosis of AD, including earliest diagnostic stage of preclinical AD, which has the highest potential for research, including diagnosis and disease modification. We discuss both FDA-approved pharmacologic treatments, a...
The current criteria for classification of Alzheimer's disease (AD) have deficiencies that limit drug development, research, and practice. The current standard for the clinical diagnosis of AD, the National Institute of Neurological and Communicative Disorders and Stroke (now known as the National Ins...
The authors comments on a research on the relationship of cognitive measures and gray and white matter in Alzheimer's disease (AD). According to them, the importance of the study lies primarily in improving the current understanding of AD and the diagnostic tools used in its assessment. The st...
doi:info:doi/10.1016/0924-977X(96)87389-5Unterbeck, AEuropean NeuropsychopharmacologyA. Unterbeck. Pharamaceutical research and development activities in Alzheimerus disease, Eur. Neuropsychopharmacol. 6: 20 (1996).
language=engThis document summarizes a report on the current state of knowledge of the etiology, diagnosis, and treatment of Alzheimers disease and on the primary research activities carried out in these areas during the year 2000 under the auspices of the National Institute of Aging and other ...
https://www.facebook.com/insnewsnetinsnewsnet